This retrospective analysis was undertaken to identify the incidence, distribution, duration, and possible causes of upper extremity neuropathy in hepatic transplant recipients. The data presented here indicate that upper extremity neuropathy is more prevalent than previously reported. The causes are probably multifactorial and may be potentiated or prolonged by the administration of CsA.
|Original language||English (US)|
|Number of pages||2|
|Issue number||1 SUPPL. 1|
|State||Published - Jan 1 1988|
ASJC Scopus subject areas